Quick Answer
HAEMONETICS CORP reported Long Term Debt of $921.23 million for the year ending 2025.
- HAEMONETICS CORP showed an increase of +15.5% in Long Term Debt from 2024 to 2025.
- This data is from HAEMONETICS CORP's annual report (Form 10-K), filed with the SEC on May 21, 2025.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $4.38 million | Q3 2010: $4.42 million | Q4 2010: $4.19 million | Q2 2011: $3.61 million | Q3 2011: $3.33 million | Q4 2011: $3.11 million | Q2 2012: $2.64 million | Q3 2012: $477.40 million | Q4 2012: $468.25 million | Q2 2013: $448.12 million | Q3 2013: $420.71 million | Q4 2013: $406.42 million | Q2 2014: $429.01 million | Q3 2014: $428.25 million | Q4 2014: $421.01 million | Q2 2015: $399.45 million | Q3 2015: $387.72 million | Q4 2015: $380.81 million | Q2 2016: $352.91 million | Q3 2016: $336.51 million | Q4 2016: $270.00 million | Q2 2017: $237.17 million | Q3 2017: $178.02 million | Q4 2017: $118.70 million | Q2 2018: $330.84 million | Q3 2018: $330.99 million | Q4 2018: $326.62 million | Q2 2019: $318.14 million | Q3 2019: $313.98 million | Q4 2019: $309.74 million | Q2 2020: $296.89 million | Q3 2020: $297.02 million | Q4 2020: $292.72 million | Q2 2021: $767.35 million | Q3 2021: $698.04 million | Q4 2021: $633.12 million | Q2 2022: $763.14 million | Q3 2022: $759.55 million | Q4 2022: $756.83 million | Q2 2023: $751.38 million | Q3 2023: $748.66 million | Q4 2023: $856.85 million | Q2 2024: $1.22 billion | Q3 2024: $1.22 billion | Q4 2024: $1.22 billion | Q1 2025: $921.23 million | Q2 2025: $920.83 million | Q3 2025: $920.39 million | Q4 2025: $919.99 million.
- Over the full 16 years of available data (2010 to 2025), HAEMONETICS CORP's Long Term Debt has grown by 20,564.6%.
- Historical annual values: Fiscal year 2025: $921.23 million | Fiscal year 2024: $797.56 million | Fiscal year 2023: $754.10 million | Fiscal year 2022: $559.44 million | Fiscal year 2021: $690.59 million | Fiscal year 2020: $305.51 million | Fiscal year 2019: $322.45 million | Fiscal year 2018: $59.42 million | Fiscal year 2017: $253.63 million | Fiscal year 2016: $364.53 million | Fiscal year 2015: $406.37 million | Fiscal year 2014: $392.06 million | Fiscal year 2013: $456.94 million | Fiscal year 2012: $2.88 million | Fiscal year 2011: $3.97 million | Fiscal year 2010: $4.46 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: